Epidemiological and clinical features associated with colonisation/ infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems

International Journal of Antimicrobial Agents

Volumn 40, Issue 3, 2012, Pages 235-238

  Fernández Cuenca, Felipe ^a   Gomez Sanchez M ^a   Rodríguez Baño, Jesús ^a   Martínez Martínez, Luis ^b,c   Vila, Jordi ^d   Bou, Germán ^e   Pascual, Alvaro ^a,f  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Microbiology Service   (Spain)

^f UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Acinetobacter baumannii; Carbapenems; Phenotypic heterogeneous resistance; Risk factors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM ISOLATE; BROTH DILUTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITAL BED; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARENTERAL NUTRITION; PHENOTYPE; PHENOTYPIC HETEROGENOUS RESISTANCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURGICAL WARD; URINALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; COHORT STUDIES; FEMALE; HUMANS; IMIPENEM; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864618109     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.05.005     Document Type: Article

References (26)

1. L. Poirel, and P. Nordmann Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology Clin Microbiol Infect 12 2006 826 836 (Pubitemid 44151282)
2. L. Dijkshoorn, A. Nemec, and H. Seifert An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii Nat Rev Microbiol 5 2007 939 951 (Pubitemid 350131182)
3. F. Perez, A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather, and R.A. Bonomo Global challenge of multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 3471 3484 (Pubitemid 47519332)
4. J. Garnacho-Montero, and R. Amaya-Villar Multiresistant Acinetobacter baumannii infections: epidemiology and management Curr Opin Infect Dis 23 2010 332 339
5. J. Vila, and J. Pachón Therapeutic options for Acinetobacter baumannii infections Expert Opin Pharmacother 9 2008 587 599 (Pubitemid 351425386)
6. L.L. Maragakis, and T.M. Perl Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options Clin Infect Dis 46 2008 1254 1263 (Pubitemid 351589912)
7. J. Rodríguez-Baño, L. García, E. Ramírez, L. Martínez-Martínez, M.A. Muniain, and F. Fernández-Cuenca Long-term control of hospital-wide endemic multidrug-resistant (MDR) Acinetobacter baumannii through a comprehensive "bundle" approach Am J Infect Control 37 2009 715 722
8. J.M. Cisneros, J. Rodríguez-Baño, F. Fernández- Cuenca, A. Ribera, J. Vila, and A. Pascual Risk factors for the treatment of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study Clin Microbiol Infect 11 2005 874 878
9. M. del Mar Tomas, M. Cartelle, S. Pertega, A. Beceiro, P. Llinares, and D. Canle Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection Clin Microbiol Infect 11 2005 540 546 (Pubitemid 40895153)
10. E.G. Playford, J.C. Craig, and J.R. Iredell Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences J Hosp Infect 65 2007 204 211
11. G. Baran, A. Erbay, H. Bodur, P. Ongürü, E. Akinci, and N. Balaban Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections Int J Infect Dis 12 2008 16 21
12. M.E. Falagas, G.C. Makris, G. Dimopoulos, and D.K. Matthaiou Heteroresistance: a concern of increasing clinical significance? Clin Microbiol Infect 14 2008 101 104
13. N.Q. Balaban, J. Merrin, R. Chait, L. Kowalik, and S. Leibler Bacterial persistence as a phenotypic switch Science 305 2004 1622 1625 (Pubitemid 39296357)
14. A. Pascual, L. Martínez-Martínez, M.J. Clavijo, M.D. García-Perea, and E.J. Perea Comparison of three methods of determining the in vitro susceptibilities of Acinetobacter baumannii isolates to imipenem J Antimicrob Chemother 40 1997 742 743 (Pubitemid 27504015)
15. S. Pournaras, A. Ikonomidis, A. Markogiannakis, A.N. Maniatis, and A. Tsakris Heteroresistance to carbapenems in Acinetobacter baumannii J Antimicrob Chemother 55 2005 1055 1056
16. J. Li, C.R. Rayner, R.L. Nation, R.J. Owen, D. Spelman, and K.E. Tan Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 50 2006 2946 2950 (Pubitemid 44396396)
17. J.S. Hawley, C.K. Murray, and J.H. Jorgensen Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy Antimicrob Agents Chemother 52 2008 351 352
18. F. Fernández-Cuenca, P. Egea, L. López-Cerero, P. Díaz-De Alba, J. Vila, and A. Pascual Comparison of 3 methods for determining sensitivity to imipenem and meropenem in Acinetobacter baumannii with a carbapenem-heteroresistant phenotype Enferm Infecc Microbiol Clin 26 2008 485 488 [in Spanish]
19. A. Ikonomidis, E. Neou, V. Gogou, G. Vrioni, A. Tsakris, and S. Pournaras Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii J Clin Microbiol 47 2009 4055 4059
20. H.Y. Lee, C.L. Chen, S.B. Wang, L.H. Su, S.H. Chen, and S.Y. Liu Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications Int J Antimicrob Agents 37 2011 302 308
21. K.H. Hung, M.C. Wang, A.H. Huang, J.J. Yan, and J.J. Wu Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii J Clin Microbiol 50 2012 721 726
22. F. Fernández Cuenca, M.C. Gómez Sánchez, F. Caballero-Moyano, J. Vila, L. Martínez Martínez, and G. Bou Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii Int J Antimicrob Agents 39 2012 472 477
23. F. Fernández-Cuenca, A. Pascual, A. Ribera, J. Vila, G. Bou, and J.M. Cisneros Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000) Enferm Infecc Microbiol Clin 22 2004 267 271 [in Spanish] (Pubitemid 38756624)
24. J. Rodríguez-Baño, J.M. Cisneros, F. Fernández- Cuenca, A. Ribera, J. Vila, and A. Pascual Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals Infect Control Hosp Epidemiol 25 2004 819 824 (Pubitemid 40036756)
25. Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M07-A7. Wayne, PA: CLSI; 2006.
26. W.R. McCabe, and G.G. Jackson Gram-negative bacteremia I: etiology and ecology Arch Intern Med 110 1962 847 855